Stock Markets April 27, 2026 10:32 AM

Arm, GE Vernova Lead Broad Market Moves as Chips and Biotech See Volatility

Mega-cap technology names slip while select mid- and small-cap biotech and industrial stocks post sharp gains and losses

By Derek Hwang ARM GEV AMD TSLA BABA
Arm, GE Vernova Lead Broad Market Moves as Chips and Biotech See Volatility
ARM GEV AMD TSLA BABA

Equity markets on Monday displayed notable volatility across market-cap tiers. Mega-cap technology and industrial names, including Arm and GE Vernova, posted declines, while several semiconductor, biotech and industrial mid-caps and small-caps experienced outsized moves driven by company-specific news and trial results.

Key Points

  • Mega-cap technology and industrial stocks, including Arm and GE Vernova, showed declines while Micron and Intel posted gains.
  • Mid-cap and small-cap moves were often linked to company-specific items such as trial results, order cancellations, downgrades, and acquisition announcements.
  • Sectors impacted include semiconductors, biotech/clinical-stage therapeutics, industrials and specialty chemicals.

Stock prices moved unevenly across U.S. markets on Monday, with several large-cap technology and industrial names retreating while a mix of mid-cap and small-cap companies showed large percentage swings tied to corporate news and clinical updates.

The most pronounced moves touched a wide array of sectors, from semiconductors and cloud software to specialty chemicals and biotech. Below are the day's notable movers, grouped by market-cap range and reported with the percentage changes given in the market data.


Mega-Cap Movers ($200B+ Market Cap)

  • Arm (ARM): -9.53%
  • GE Vernova LLC (GEV): -3.26% - BNP Paribas Exane downgrades GE Vernova stock rating to neutral
  • Advanced Micro Devices (AMD): -3.88%
  • Tesla Motors (TSLA): -2.51%
  • Alibaba-exch (BABA): -2.56%
  • Oracle Corp (ORCL): -1.45%
  • Micron Tech (MU): +4.16%
  • Intel Corp (INTC): +1.96%

Large-Cap Movers ($10B-$200B Market Cap)

  • Applied Opt (AAOI): -10.58%
  • Dominos Pizza Inc (DPZ): -10.06%
  • Rambus Inc (RMBS): -8.17%
  • Credo Technology Holding (CRDO): -7.88%
  • Astera Labs (ALAB): -7.27%
  • Lumentum Holdings Inc (LITE): -4.94%
  • Stanley Works (SWK): +1.44%
  • Venture Global Inc (VG): +5.59%
  • SanDisk Corp-Exch (SNDK): +5.18%
  • Qualcomm Inc (QCOM): -0.26%

Mid-Cap Movers ($2B-$10B Market Cap)

  • POET Tech NAQ (POET): -45.0% - Poet Technologies loses orders after Marvell cancels purchase
  • Veradermics Inc (MANE): +42.03% - Veradermics to present Phase 2/3 hair loss trial results Monday
  • ARCA biopharma (ORKA): +20.57% - ORKA-001 achieves 63.5% complete skin clearance in trial
  • Organon Co (OGN): +17.1%
  • MaxLinear Inc (MXL): -10.85%
  • Erasca (ERAS): -6.79%
  • Cleveland Cliffs (CLF): +6.81%
  • Beam Inc. (BEAM): +9.15%
  • Israel Chemicals Ltd (ICL): +6.08%
  • Chenghe Acquisition II (PLBL): -2.55%

Small-Cap Movers ($300M-$2B Market Cap)

  • Compass Therapeutics, NAQ (CMPX): -52.69% - Compass Therapeutics' tovecimig meets PFS endpoint in bile duct cancer
  • Real Brokerage USA (REAX): -26.68%
  • Velo3D (VELO): -20.16%
  • AAOX (AAOX): -21.33%
  • LightPath Technol (LPTH): -14.23%
  • LITX (LITX): -10.41%
  • AMDL (AMDL): -8.3%
  • Pegasus Digital Mobility (SHMD): -5.95% - SCHMID Group reports Q1 order intake of €13.6M, reaffirms 2026 guidance
  • XOMA Ltd (XOMA): +9.39% - Ligand to acquire XOMA Royalty for $739 million in cash
  • MUU (MUU): +7.8%

The trading day featured both company-specific catalysts and analyst action. Examples included a bank downgrade on GE Vernova and a cancelled order that weighed heavily on POET Tech. Clinical trial readouts and acquisition announcements supported gains for several biotech and small-cap companies.

Market participants saw a mix of declines among large-cap technology and industrial names, while specific biotech and specialty industrial stocks recorded sharp rallies or steep declines tied to trial outcomes, corporate actions, and order changes.

Readers should note that the data above reflects the reported percentage moves and the limited contextual notes that accompanied specific tickers; the summaries remain confined to the facts provided with each stock listing.

Risks

  • Analyst action can weigh on industrial and energy-related stocks, as seen with the BNP Paribas Exane downgrade of GE Vernova, affecting investor sentiment in industrial sectors.
  • Order cancellations and customer actions can produce abrupt revenue and share-price shocks for technology suppliers, illustrated by Poet Technologies losing orders after Marvell cancelled a purchase.
  • Clinical trial readouts and acquisition-related disclosures introduce event-driven volatility for biotech and small-cap companies, reflected in the large percentage moves for Veradermics, ARCA biopharma, Compass Therapeutics and XOMA.

More from Stock Markets

Milan Session Ends Marginally Higher as Financials, Oil & Gas and Healthcare Support Market Apr 27, 2026 Amsterdam market dips as tech, telecoms and energy drag AEX down 1.15% Apr 27, 2026 Portuguese Market Closes Higher as Utilities, Consumer Goods and Basic Materials Lead Gains Apr 27, 2026 Madrid Stocks Tick Up Mildly at Close as Energy and Tech Names Lead Gains Apr 27, 2026 U.K. equities slip as mining, autos and telecom stocks weigh on market Apr 27, 2026